5 Best Biotech Penny Stocks to Buy in 2026

Page 1 of 5

In this article, we will list the 5 Best Biotech Penny Stocks to Buy in 2026. Please visit 9 Best Biotech Penny Stocks to Buy in 2026 to see the extended list and the methodology behind it.

5. Absci Corporation (NASDAQ:ABSI)

Number of Hedge Fund Holders: 16

Absci Corporation (NASDAQ:ABSI) is one of the best biotech penny stocks to buy in 2026. On March 24, Absci reported Q4 and the full-year 2025 financial results, highlighting significant progress in its internal pipeline of AI-designed therapeutics. The company dosed the first three cohorts in its HEADLINE Phase 1/2a trial for ABS-201, a novel anti-PRLR antibody targeting androgenetic alopecia. Emerging data indicates the treatment is well-tolerated, and recent ex vivo studies suggest ABS-201 can stimulate hair growth by regenerating the follicle stem cell niche.

5 Best Biotech Penny Stocks to Buy in 2026

Absci expects to release preliminary safety and pharmacokinetic data in H1 2026, followed by interim proof-of-concept results in H2. The company is also diversifying the application of ABS-201 by preparing to initiate a Phase 2 trial for endometriosis in the fourth quarter of 2026. This expansion targets a significant unmet need for non-sex steroid hormone treatments in a market affecting millions of women.

Financially, Absci reported a full-year net loss of $115.2 million for 2025, with R&D expenses rising to $81.4 million as internal programs moved toward the clinic. Despite the increase in spending, the company maintains a solid balance sheet with $144.3 million in cash, cash equivalents, and marketable securities as of December 31. Management noted that this capital is sufficient to fund operations into H1 2028. Looking forward, Absci Corporation (NASDAQ:ABSI) anticipates signing at least one major drug creation partnership with a large pharmaceutical company during 2026.

Absci Corporation (NASDAQ:ABSI) develops several antibody therapeutics.

Page 1 of 5